4.5 (430) In stock
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities - ScienceDirect
PDF) Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer, Molecular Cancer
Research articles Cell Death Discovery
Cancers, Free Full-Text
HER2-positive MedChemExpress (MCE) Life Science Reagents
Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin)
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
Salinomycin suppresses STAT3 activation. (A) Basal levels of STAT3 and
Cancers, Free Full-Text
Expression of 611-CTF in mouse mammary glands results in mild abnormal
PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
Characterization of p95HER2/611CTF-positive breast cancers and effect
